Vitalhub (TSE:VHI) Director Francis Nelson Shen Acquires 439,600 Shares

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen acquired 439,600 shares of the business’s stock in a transaction that occurred on Tuesday, March 24th. The stock was purchased at an average price of C$7.00 per share, for a total transaction of C$3,077,200.00. Following the completion of the transaction, the director owned 588,300 shares in the company, valued at C$4,118,100. The trade was a 295.63% increase in their ownership of the stock.

Francis Nelson Shen also recently made the following trade(s):

• On Thursday, March 26th, Francis Nelson Shen bought 50,000 shares of Vitalhub stock. The stock was acquired at an average price of C$6.99 per share, for a total transaction of C$349,500.00.

Vitalhub Stock Down 0.7%

Vitalhub stock traded down C$0.05 during mid-day trading on Friday, hitting C$6.93. 208,775 shares of the company’s stock traded hands, compared to its average volume of 359,939. Vitalhub Corp. has a one year low of C$6.67 and a one year high of C$14.64. The firm has a 50 day moving average price of C$8.10 and a 200 day moving average price of C$9.35. The company has a market cap of C$438.20 million, a PE ratio of 69.30, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65.

Vitalhub (TSE:VHI) last released its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The company had revenue of C$31.39 million during the quarter. On average, analysts expect that Vitalhub Corp. will post 0.2296467 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on VHI shares. Royal Bank Of Canada dropped their price target on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a report on Monday, January 26th. Raymond James Financial cut their target price on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Tuesday. Scotiabank reduced their target price on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Finally, ATB Cormark Capital Markets dropped their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. One investment analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.